Florida
|
000-29819
|
58-2349413
|
(State
or other jurisdiction of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
850
Third Avenue
Suite
1801
New
York, New York
|
10022
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR
240.13e-4(c))
|
HEPALIFE
TECHNOLOGIES, INC.
|
||||
Dated: May 18, 2010 |
By:
|
/s/ Steven C. Berger | ||
Name: |
Steven
C. Berger
|
|||
Title: |
Chief
Financial Officer
|
|||